Iceland· IS-EU/1/24/1881/005-006
Alhemo
A concizumab product containing concizumab, registered in Iceland by Novo Nordisk A/S*. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Concizumab is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BX10 (concizumab), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Concizumab · ATC B02BX10
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of concizumab costs, country by country.
Normalised to the WHO defined daily dose (14 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Concizumab · price per daily dose (14 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1227.21
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Concizumab
- Manufacturer
- Novo Nordisk A/S*
- Country
- Iceland (IS)
- ATC code
- B02BX10
- ATC class
- Concizumab
- Defined daily dose
- 14 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Concizumab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALHEMONovo Nordisk A/S, Bagsvaerd
- SwitzerlandAlhemo
- BelgiumAlhemo 150 mg/1.5 mlNovo Nordisk
- SpainALHEMO 150 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADANovo Nordisk A/S
- SwedenAlhemo 150 mg/1,5 ml Injektionsvätska, lösning i förfylld injektionspennaNovo Nordisk A/S
- PolandAlhemoNovo Nordisk A/S
- FinlandAlhemoNovo Nordisk A/S
- IrelandAlhemo 15 mg/1.5 mL solution for injection in pre-filled penNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Norway · Alhemo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0aabd9d4-672d-431e-aca2-8c40fb7187ce GET /v1/drugs/0aabd9d4-672d-431e-aca2-8c40fb7187ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn í áfylltum lyfjapenna",
"source": "lyfjastofnun",
"atc_raw": "B02BX10",
"marketed": false,
"strength": "150 mg/1,5 ml",
"ma_number": "EU/1/24/1881/005-006",
"substance": "Concizumab",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í blóðsjúkdómum.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "45639"
}See everything about concizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.